Endocrine disruptors can affect cancer risk by altering the normal regulatory mechanisms of cell growth and differentiation. For instance, these chemicals can bind to hormone receptors and activate or inhibit hormonal pathways improperly. This can lead to the uncontrolled cell division associated with cancer development. Specifically, they have been linked to cancers of the breast, prostate, and thyroid.